USP Advisory Group To Evaluate International Harmonization Efforts
This article was originally published in The Pink Sheet Daily
A committee comprising stakeholders will discuss ways of improving USP's work with international pharmacopeias to harmonize excipient monographs and general chapters.
You may also be interested in...
The firm will restate first quarter and 2004 year-end results due to less-than-expected returns of the anabolic agent.
FDA approves bisphosphonate line extension featuring four days of risedronate dosing and 24 days of calcium supplementation.
Indevus expects Nebido to acquire the majority of the injectable testosterone hypogonadism treatment market when it launches in the U.S., the company said in an Aug. 9 earnings call